Effective use of liquid chromatography-mass spectrometry (LC/MS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus, and cyclosporine

被引:47
作者
Poquette, MA [1 ]
Lensmeyer, GL [1 ]
Doran, TC [1 ]
机构
[1] Univ Wisconsin Hosp & Clin, Toxicol Lab, Clin Labs, Madison, WI 53792 USA
关键词
tacrolimus; sirolimus; cyclosporine; liquid chromatography; mass spectrometry;
D O I
10.1097/01.ftd.0000148451.35811.74
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The authors describe an isocratic liquid chromatographic/electrospray single quadrupole mass spectrometric assay suitable for routine therapeutic monitoring of the antirejection drugs tacrolimus, sirolimus, and cyclosporine in blood. The drugs and added internal standards, ascomycin, desmethoxysirolimus, and cyclosporine G, are extracted from a protein-free supernatant of patient blood on a Strata SDB-L styrene-divinylbenzene polymeric extraction cartridge (Phenomenex, Torrance, CA). A Gilson Aspec XL-4 (Gilson Instruments, Middleton, WI) is programmed to perform the extraction and transfer the extract to autosampler vials. The extract is automatically injected onto a C18 column held at 75 degrees C. Mobile phase, acetonitrile/water 90/10 (vol/vol), is pumped at 0.5 mL/min through a silica saturating column positioned in the column oven before the injector valve. Detection is by selected ion monitoring of the sodium adduct of each analyte, [M + 23](+). A linear response is achieved for tacrolimus and sirolimus from limit of quantitation (LOQ) 1.0 mu g/L to at least 80.0 mu g/L. Cyclosporine was linear from LOQ 25 mu g/L to at least 2000 mu g/L. Interferences and ionization suppression are minimal. Analytic recovery for cyclosporine is 99.9 +/- 6.2% over a range of 104-1162 mu g/L; sirolimus 107.7 +/- 9.3% over a range of 3.2-29.2 mu g/L; and tacrolimus 101.9 +/- 2.5% over a range of 2.9-38.1 mu g/L. Between-run relative standard deviations are 3.0% to 5.1% over a range of 9.8 mu g/L to 30.7 mu g/L for tacrolimus; 5.5% to 7.6% over a range of 13.5 mu g/L to 35.2 mu g/L for sirolimus; and 2.6% to 4.3% over a range of 186.0 mu g/L to 1428.7 mu g/L for cyclosporine. In the authors' laboratory, the method is robust and shows improved selectivity, precision, detection limits, and lower cost per test over available immunoassays. The authors find the method suitable for routine monitoring and therapy management of these drugs with over 50,000 samples analyzed over the course of 1 year.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 15 条
[1]   Ion suppression in mass spectrometry [J].
Annesley, TM .
CLINICAL CHEMISTRY, 2003, 49 (07) :1041-1044
[2]   IMPROVEMENTS IN LIQUID-CHROMATOGRAPHY COLUMN LIFE AND METHOD FLEXIBILITY BY SATURATING THE MOBILE PHASE WITH SILICA [J].
ATWOOD, JG ;
SCHMIDT, GJ ;
SLAVIN, W .
JOURNAL OF CHROMATOGRAPHY, 1979, 171 (APR) :109-115
[3]   Quantitation of SR 27417 in human plasma using electrospray liquid chromatography tandem mass spectrometry: A study of ion suppression [J].
Buhrman, DL ;
Price, PI ;
Rudewicz, PJ .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 1996, 7 (11) :1099-1105
[4]   Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants [J].
Christians, U ;
Jacobsen, W ;
Serkova, N ;
Benet, LZ ;
Vidal, C ;
Sewing, KF ;
Manns, MP ;
Kirchner, GI .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 748 (01) :41-53
[5]   Simultaneous quantification of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography-mass spectrometry (LC-MS) [J].
Deters, M ;
Kirchner, G ;
Resch, K ;
Kaever, V .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (03) :285-292
[6]   Mechanistic investigation of ionization suppression in electrospray ionization [J].
King, R ;
Bonfiglio, R ;
Fernandez-Metzler, C ;
Miller-Stein, C ;
Olah, T .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2000, 11 (11) :942-950
[7]  
LENSMEYER GL, 1987, CLIN CHEM, V33, P1841
[8]   Therapeutic monitoring of tacrolimus concentrations in blood: Semi-automated extraction and liquid chromatography-electrospray ionization mass spectrometry [J].
Lensmeyer, GL ;
Poquette, MA .
THERAPEUTIC DRUG MONITORING, 2001, 23 (03) :239-249
[9]   Liquid chromatography-electrospray mass spectrometric studies of ginkgolides and bilobalide using simultaneous monitoring of proton, ammonium and sodium adducts [J].
Li, XF ;
Ma, MS ;
Scherban, K ;
Tam, YK .
ANALYST, 2002, 127 (05) :641-646
[10]   Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology [J].
Marquet, P .
THERAPEUTIC DRUG MONITORING, 2002, 24 (02) :255-276